Ephedrine case: SC issues notice to Ali Musa Gilani
Former DG ANF also issued notice, Musa Gilani leaves for South Africa.
ISLAMABAD:
The Supreme Court of Pakistan issued a notice to Ali Musa Gilani, son of Prime Minister Yousaf Raza Gilani in the Ephedrine case on Tuesday, reported Express News.
Former DG Anti-Narcotics Force (ANF) Major General Shakil has also been issued a notice, while later during the day, Musa Gilani left for South Africa.
Earlier today, ANF had also requested the Interior Ministry to add Musa Gilani's name to the Exit Control List.
According to sources, ANF officials informed Chief Justice Iftikhar Muhammad Chaudhry that secretary narcotics was trying to protect Musa Gilani. The chief justice was reported to have said that this was a sensitive issue, where they needed to tread carefully.
The case regarding the illegal sale of Ephedrine was registered on October 10 last year, after two pharmaceutical companies — Danas Pharmaceutical Limited and Berlex Lab International – were accused of obtaining export quotas for the drug in collusion with the health ministry officials that exceeded the limits fixed by the International Narcotics Control Board (INCB).
The INCB had fixed an annual quota of 22,000kg of ephedrine for Pakistan for 2010-11, but the ministry of health following its devolution allocated a quota of around 31,000kg of the drug.
Later, ANF’s investigation had allegedly established a direct link between Ali Musa Gilani and the multi-billion drug scandal.
Correction: Due to a typographical error, 'Ephedrine' was earlier misspelled as 'Epherdine' in the headline. The error has been rectified.
The Supreme Court of Pakistan issued a notice to Ali Musa Gilani, son of Prime Minister Yousaf Raza Gilani in the Ephedrine case on Tuesday, reported Express News.
Former DG Anti-Narcotics Force (ANF) Major General Shakil has also been issued a notice, while later during the day, Musa Gilani left for South Africa.
Earlier today, ANF had also requested the Interior Ministry to add Musa Gilani's name to the Exit Control List.
According to sources, ANF officials informed Chief Justice Iftikhar Muhammad Chaudhry that secretary narcotics was trying to protect Musa Gilani. The chief justice was reported to have said that this was a sensitive issue, where they needed to tread carefully.
The case regarding the illegal sale of Ephedrine was registered on October 10 last year, after two pharmaceutical companies — Danas Pharmaceutical Limited and Berlex Lab International – were accused of obtaining export quotas for the drug in collusion with the health ministry officials that exceeded the limits fixed by the International Narcotics Control Board (INCB).
The INCB had fixed an annual quota of 22,000kg of ephedrine for Pakistan for 2010-11, but the ministry of health following its devolution allocated a quota of around 31,000kg of the drug.
Later, ANF’s investigation had allegedly established a direct link between Ali Musa Gilani and the multi-billion drug scandal.
Correction: Due to a typographical error, 'Ephedrine' was earlier misspelled as 'Epherdine' in the headline. The error has been rectified.